Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 3/20 | 0.42 |
| ▸ | F2RL1 | P55085 | 8/20 | 0.40 |
| ▸ | TXN | P10599 | 1/20 | 0.40 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP7 | P09237 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29012442 | 0.98 | FPR2 (0.41) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| Bromide SCHEMBL29172260 | 0.98 | FPR2 (0.41) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| Sulfuric Acid SCHEMBL28689223 | 0.90 | FPR2 (0.42) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| SCHEMBL11627014 | 0.89 | CYP1A2 (0.42) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| SCHEMBL18125130 | 0.89 | CYP1A2 (0.42) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| Sulfuric Acid SCHEMBL29204981 | 0.88 | FPR2 (0.39) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| SCHEMBL5610773 | 0.87 | GPR84 (0.43) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| SCHEMBL11687199 | 0.85 | GPR84 (0.46) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| SCHEMBL78832 | 0.85 | GPR84 (0.46) | FPR2F2RL1TXNTXNRD1ADRA2A | |
| SCHEMBL905199 | 0.85 | GPR84 (0.46) | FPR2F2RL1TXNTXNRD1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129487-A1 | PRODUCTION METHOD FOR AMMONIA AND PRODUCTION DEVICE | NISSAN CHEMICAL CORPORATION (JP) | 2025-04-24 | — | — | US | disclosed |
| US-20240328014-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | THE UNIVERSITY OF TOKYO (JP) | 2024-10-03 | — | — | US | disclosed |
| WO-2024098840-A1 | ISOBUTYLENE-BASED CATIONIC SALT POLYMER, PREPARATION METHOD THEREFOR, USE THEREOF, AND ANTIBACTERIAL POLYMER MATERIAL | 中国石油化工股份有限公司 | 2024-05-16 | — | — | WO | disclosed |
| US-20230295813-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230295818-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | THE UNIVERSITY OF TOKYO (JP) | 2023-09-21 | — | — | US | disclosed |
| WO-2023113033-A1 | GAS DIFFUSION ELECTRODE | 日産化学株式会社 | 2023-06-22 | — | — | WO | disclosed |
| WO-2023106424-A1 | PRODUCTION METHOD FOR AMMONIA AND PRODUCTION DEVICE | 日産化学株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-116194211-A | Method and apparatus for producing ammonia | 日产化学株式会社 | 2023-05-30 | — | — | CN | disclosed |
| WO-2022210912-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | 国立大学法人東京大学 | 2022-10-06 | — | — | WO | disclosed |
| WO-2022210775-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | 国立大学法人東京大学 | 2022-10-06 | — | — | WO | disclosed |
| US-20160276109-A1 | Solid Organic Electrolytes | CLARKSON UNIVERSITY (US) | 2016-09-22 | — | — | US | disclosed |
| US-9293786-B1 | Solid organic electrolytes | CLARKSON UNIVERSITY (US) | 2016-03-22 | — | — | US | disclosed |
| CN-103361630-A | Group 2 imidazolate formulations for direct liquid injection | AIR PROD & CHEM | 2013-10-23 | — | — | CN | disclosed |
| US-8476269-B2 | Pyridine and pyrazine derivative for the treatment of CF | NOVARTIS AG (CH) | 2013-07-02 | — | — | US | disclosed |
| US-20120277232-A1 | Pyridine and Pyrazine Derivative for the Treatment of CF | NOVARTIS AG | 2012-11-01 | — | — | US | disclosed |
| US-8247436-B2 | Pyridine and pyrazine derivative for the treatment of CF | NOVARTIS AG (CH) | 2012-08-21 | — | — | US | disclosed |
| CN-102344413-A | Volatile imidazoles and group 2 imidazole based metal precursors | AIR PROD & CHEM | 2012-02-08 | — | — | CN | disclosed |
| US-20110230483-A1 | Pyridine and Pyrazine derivative for the Treatment of CF | NOVARTIS AG | 2011-09-22 | — | — | US | disclosed |
| EP-0797789-B1 | NOVEL DIHYDRAZIDES AS DOT-PROMOTING AGENTS IN PHOTOGRAPHIC IMAGE SYSTEMS | INT PAPER CO (US) | 1998-11-25 | — | — | EP | disclosed |
| EP-0797789-A1 | NOVEL DIHYDRAZIDES AS DOT-PROMOTING AGENTS IN PHOTOGRAPHIC IMAGE SYSTEMS | ILFORD AG (CH) | 1997-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230483-A1 | Pyridine and Pyrazine derivative for the Treatment of CF | CFTR, OPRK1, OPRD1 | FPR2 1015/4885F2RL1 3449/4885TXN 2132/4885 |
| US-20120277232-A1 | Pyridine and Pyrazine Derivative for the Treatment of CF | CFTR, OPRK1, OPRD1 | FPR2 1015/4885F2RL1 3449/4885TXN 2132/4885 |
| US-20240328014-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | ASNS, ASS1, CPS1 | FPR2 4391/4885F2RL1 4793/4885TXN 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.